Sign in

CIK 0001576280

  • Large accelerated filer

Guardant Health, Inc.

Sign in to watch
Ticker
GH
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454139254
Phone
+1 855-698-8887
Business address
3100 HANOVER STREET, PALO ALTO, CA, 94304
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,952,385
in 10 filings, $770K under 10b5-1 plans

Net −$3,952,385. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-15 Kalia Kumud Chief Information Officer Exercise or conversion · Restricted Stock Units −637 3,187
2025-03-15 Freeman Chris Chief Commercial Officer Exercise or conversion +1,401 40,190
2025-03-15 Freeman Chris Chief Commercial Officer Shares withheld for taxes −387 $42.89 $17K 39,803
2025-03-15 Freeman Chris Chief Commercial Officer Exercise or conversion · Restricted Stock Units −1,401 7,010
2025-03-15 EAGLE CRAIG Chief Medical Officer Exercise or conversion +1,401 31,014
2025-03-15 EAGLE CRAIG Chief Medical Officer Shares withheld for taxes −500 $42.89 $21K 30,514
2025-03-15 EAGLE CRAIG Chief Medical Officer Exercise or conversion · Restricted Stock Units −1,401 7,010
2025-03-15 Bell Michael Brian Chief Financial Officer Exercise or conversion +1,233 38,981
2025-03-15 Bell Michael Brian Chief Financial Officer Exercise or conversion +2,039 41,020
2025-03-15 Bell Michael Brian Chief Financial Officer Shares withheld for taxes −1,659 $42.89 $71K 39,361
2025-03-15 Bell Michael Brian Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,233 4,932
2025-03-15 Bell Michael Brian Chief Financial Officer Exercise or conversion · Restricted Stock Units −2,039 10,195
2025-03-14 Talasaz AmirAli Co-Chief Executive Officer Exercise or conversion +68,769 2,330,100
2025-03-14 Talasaz AmirAli Co-Chief Executive Officer Shares withheld for taxes −34,853 $42.89 $1.5M 2,295,247
2025-03-14 Talasaz AmirAli Co-Chief Executive Officer Exercise or conversion · Performance-Based Restricted Stock Units −68,769 0
2025-03-14 Eltoukhy Helmy Co-Chief Executive Officer Exercise or conversion +68,769 2,429,934
2025-03-14 Eltoukhy Helmy Co-Chief Executive Officer Shares withheld for taxes −34,853 $42.89 $1.5M 2,395,081
2025-03-14 Eltoukhy Helmy Co-Chief Executive Officer Exercise or conversion · Performance-Based Restricted Stock Units −68,769 0
2025-03-12 Talasaz AmirAli Co-Chief Executive Officer Grant or award · Restricted Stock Units +19,258 19,258
2025-03-12 Talasaz AmirAli Co-Chief Executive Officer Grant or award · Restricted Stock Units +116,010 116,010

Page 54 of 57 · 1,133 trades